Kristen Yen - 15 Dec 2025 Form 4 Insider Report for SOLENO THERAPEUTICS INC (SLNO)

Role
Officer title: SVP Global Clinical Operations and Patient Advocacy
Signature
/s/ Anish Bhatnagar, Attorney-in-Fact
Issuer symbol
SLNO
Transactions as of
15 Dec 2025
Net transactions value
-$45,155
Form type
4
Filing time
17 Dec 2025, 16:39:44 UTC
Previous filing
31 Mar 2025
Next filing
23 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Yen Kristen Officer title: SVP Global Clinical Operations and Patient Advocacy 100 MARINE PARKWAY, SUITE 400, REDWOOD CITY /s/ Anish Bhatnagar, Attorney-in-Fact 17 Dec 2025 0001643441

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SLNO Common Stock Tax liability $45,155 -904 -3.2% $49.95 27,239 15 Dec 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units ("RSUs") which vested on December 15, 2025.
F2 Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU.

Remarks:

Officer title: SVP Global Clinical Operations and Patient Advocacy